Ramoil Management, Ltd. Announces Purchase of Supercritical CO2 Extraction Machinery

IRVINE, CA--(Marketwired - Sep 10, 2015) -  RAMOIL MANAGEMENT,LTD. (OTC PINK: RAMO) announced the purchase of a new Supercritical CO2 Extraction Machine for its growing division of CBD product lines. Ramoil Management also highlights promising preclinical studies recently released regarding the therapeutic benefits of CBD.

Ramoil Executive Director, Woo Kim, spoke about the company's recent purchase of the new Supercritical CO2 Extraction machine. "We obtained a 20L Supercritical CO2 extraction machine for maximum efficiency; vapor oil, lotions, and flavorful edibles are just a few of the products we are developing with this new technology. The extraction machine will be at full production capacity within 90 days," Kim continued. "We are working with partners to distribute this merchandise in every U.S. state and ultimately help all of those in need," said Mr Kim.

According to the National Institute of Health (NIH), CBD does not produce euphoria or intoxication, and preclinical studies suggest that CBD may have several therapeutic benefits. According to the NIH study, "CBD (is shown to have) a range of effects that may be therapeutically useful, including anti-seizure, antioxidant, neuroprotective, anti-inflammatory, analgesic, anti-tumor, anti-psychotic, and anti-anxiety properties." Additional studies have shown success in the treatment of various conditions, including chronic pain, nausea, rheumatoid arthritis, schizophrenia, diabetes, PTSD, alcoholism, strokes, cardiovascular disease and other ailments.

Kim has been overseeing Jeremy Foti, CEO, building his management team, bringing on new partners and consultants, and working toward the development and acquisition of innovative new product lines. "This purchase is another significant step toward positioning our company's CBD products in the mainstream marketplace," Kim stated. "There is an increasing demand for these products as studies emerge that confirm CBD's efficacy; the momentum is definitely building a new level of excitement for us, and especially those stricken with these diseases and ailments." Foti is increasing the pace of product development and has increased staff levels to handle the demand. "Several announcements over the next few months will reveal an impressive lineup of new products," Kim concluded.

ABOUT Ramoil Management, Ltd.

Ramoil Management, Ltd. (RAMO) focuses on the development of innovative products that supply the medical, research, and pharmaceutical industries. The company is additionally establishing domestic and international partnerships with businesses that develop and sell proprietary consumer products and services related to the social marketing sector of the legal cannabis industry. New product lines for the consumer music and entertainment sectors are in development.

Forward Looking Statements: This news release contains forward-looking statements made by RAMOIL MANAGEMENT, LTD. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward-looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements. Forward- looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E ofthe Securities Exchange Act of 1934 because it is not registered under either Act.